421 related articles for article (PubMed ID: 15094367)
1. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
[TBL] [Abstract][Full Text] [Related]
2. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
[TBL] [Abstract][Full Text] [Related]
3. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes.
Lu Y; Kawakami S; Yamashita F; Hashida M
Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093
[TBL] [Abstract][Full Text] [Related]
4. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route.
Hattori Y; Kawakami S; Nakamura K; Yamashita F; Hashida M
J Pharmacol Exp Ther; 2006 Aug; 318(2):828-34. PubMed ID: 16670348
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M
Gene Ther; 1999 Jan; 6(1):121-9. PubMed ID: 10341884
[TBL] [Abstract][Full Text] [Related]
6. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
[TBL] [Abstract][Full Text] [Related]
7. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M
Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Shimokawa M; Sugita T; Niwa T; Oda A; Akashi M; Tsutsumi Y; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2004 Dec; 325(2):500-5. PubMed ID: 15530420
[TBL] [Abstract][Full Text] [Related]
9. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.
Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y
Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462
[TBL] [Abstract][Full Text] [Related]
11. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
12. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
[TBL] [Abstract][Full Text] [Related]
13. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier.
Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M
Mol Pharm; 2011 Apr; 8(2):543-54. PubMed ID: 21250746
[TBL] [Abstract][Full Text] [Related]
14. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
Sheng KC; Kalkanidis M; Pouniotis DS; Esparon S; Tang CK; Apostolopoulos V; Pietersz GA
Eur J Immunol; 2008 Feb; 38(2):424-36. PubMed ID: 18200633
[TBL] [Abstract][Full Text] [Related]
15. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.
Carstens MG; Camps MG; Henriksen-Lacey M; Franken K; Ottenhoff TH; Perrie Y; Bouwstra JA; Ossendorp F; Jiskoot W
Vaccine; 2011 Jun; 29(29-30):4761-70. PubMed ID: 21565240
[TBL] [Abstract][Full Text] [Related]
16. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
[TBL] [Abstract][Full Text] [Related]
18. Ethanol consumption modifies dendritic cell antigen presentation in mice.
Heinz R; Waltenbaugh C
Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
[TBL] [Abstract][Full Text] [Related]
19. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
[TBL] [Abstract][Full Text] [Related]
20. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy.
Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M
Biomaterials; 2010 Oct; 31(30):7813-26. PubMed ID: 20656348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
